Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: A4HDT4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.480 |
CLV_PCSK_FUR_1 | 9 | 13 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.516 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.513 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.492 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.769 |
DOC_CKS1_1 | 59 | 64 | PF01111 | 0.665 |
DOC_MAPK_gen_1 | 5 | 15 | PF00069 | 0.626 |
DOC_MAPK_MEF2A_6 | 9 | 17 | PF00069 | 0.586 |
DOC_PP1_RVXF_1 | 148 | 154 | PF00149 | 0.551 |
DOC_PP4_FxxP_1 | 59 | 62 | PF00568 | 0.598 |
DOC_WW_Pin1_4 | 58 | 63 | PF00397 | 0.513 |
LIG_Actin_WH2_2 | 42 | 57 | PF00022 | 0.497 |
LIG_EVH1_2 | 71 | 75 | PF00568 | 0.679 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.513 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.583 |
LIG_FHA_2 | 140 | 146 | PF00498 | 0.709 |
LIG_LIR_Gen_1 | 82 | 92 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.428 |
LIG_Pex14_1 | 14 | 18 | PF04695 | 0.530 |
LIG_SH2_PTP2 | 18 | 21 | PF00017 | 0.277 |
LIG_SH2_SRC | 18 | 21 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.399 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.476 |
LIG_Sin3_3 | 46 | 53 | PF02671 | 0.277 |
LIG_TRAF2_1 | 142 | 145 | PF00917 | 0.678 |
LIG_UBA3_1 | 118 | 126 | PF00899 | 0.277 |
LIG_WRC_WIRS_1 | 80 | 85 | PF05994 | 0.612 |
MOD_CDK_SPxxK_3 | 58 | 65 | PF00069 | 0.548 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.737 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.692 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.584 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.377 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.308 |
MOD_NEK2_2 | 79 | 84 | PF00069 | 0.612 |
MOD_PKA_2 | 159 | 165 | PF00069 | 0.646 |
MOD_Plk_1 | 139 | 145 | PF00069 | 0.706 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.313 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.576 |
MOD_ProDKin_1 | 58 | 64 | PF00069 | 0.511 |
TRG_DiLeu_BaEn_1 | 144 | 149 | PF01217 | 0.703 |
TRG_DiLeu_BaEn_4 | 144 | 150 | PF01217 | 0.549 |
TRG_DiLeu_BaLyEn_6 | 164 | 169 | PF01217 | 0.631 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.405 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.625 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.563 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.589 |
TRG_NLS_MonoExtC_3 | 4 | 9 | PF00514 | 0.536 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3C1 | Leptomonas seymouri | 64% | 100% |
A0A0S4IMU6 | Bodo saltans | 28% | 78% |
A0A1X0NWM1 | Trypanosomatidae | 37% | 100% |
A0A3R7LPV2 | Trypanosoma rangeli | 32% | 100% |
A0A3S7WYQ2 | Leishmania donovani | 68% | 99% |
A4I132 | Leishmania infantum | 69% | 99% |
C9ZW76 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
E9AX69 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 68% | 99% |
Q4QAA7 | Leishmania major | 69% | 100% |